Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts for Renal Response in Myeloma Patients with Severe Renal Impairment

Meletios A. Dimopoulos, MD, Maria Roussou, MD, Eftathios Kastritis, Alexandra Margeli, PhD, Evangelos Eleutherakis-Papaiakovou, MD, Ioannis Ntanasis-Stathopoulos, MD, Nikolaos Kanellias, MD, Gerasimos-Petros Papassotiriou, PhD, Despina Fotiou, MD, Magdalini Migkou, MD, Maria Gavriatopoulou, MD, Erasmia Psimenou, MD, Ioannis Papassotiriou, PhD, Evangelos Terpos, MD PhD

Blood (2019) 134 (Supplement_1): 1877.

https://doi.org/10.1182/blood-2019-123912

Published: 2019

Journal Articles

The Effect of the Soluble Guanylate Cyclase Stimulator Olinciguat on Renal Function and Biomarkers of Inflammation and Renal Injury in Sickle Cell Mice

Boris Tchernychev, PhD, Raghunath Ramanarasimhaiah, MD, Guang Liu, PhD, Katherine Hall, PhD, Regina Margaret Graul, PhD, Jaime Masferrer, PhD

Blood (2019) 134 (Supplement_1): 3554.

https://doi.org/10.1182/blood-2019-127361

Published: 2019

Journal Articles

The Impact of Different Pediatric Estimated GFR Equations on Reporting of Renal Outcomes

Jeffrey D. Lebensburger, DO, MSPH, Shreya Saxena, Jeanine Dumas, Daniel Feig, MD, Julie Kanter, MD

Blood (2019) 134 (Supplement_1): 2311.

https://doi.org/10.1182/blood-2019-131606

Published: 2019

Journal Articles

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Eftathios Kastritis, Ioannis Papassotiriou, PhD, Maria Roussou, MD, Maria Gavriatopoulou, MD, Mantzou Aimilia, PhD, Erasmia Psimenou, MD, Smaragdi Marinaki, Charikleia Gakiopoulou, MD, Alexandra Margeli, PhD, Nikolaos Kanellias, MD, Magdalini Migkou, MD, Despina Fotiou, BMBS, MA, Ioannis Ntanasis-Stathopoulos, MD, Gerasimos-Petros Papassotiriou, PhD, Aristea-Maria Papanota, MD, Evangelos Terpos, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 3126.

https://doi.org/10.1182/blood-2019-125305

Published: 2019

Journal Articles

Orosomucoid As a Biomarker for Chronic Kidney Disease Associated with Sickle Cell Anemia

Ammanuel Taye, Nathan Smith, Nowah Kokou Apeadoufia Afangbedji, Xiaomei Niu, MD, James G. Taylor, MD, Marina Jerebtsova, PhD, Sergei Nekhai, PhD

Blood (2018) 132 (Supplement 1): 2352.

https://doi.org/10.1182/blood-2018-99-119477

Published: 2018

Journal Articles

Impact of Hyperfiltration during Early Childhood on the Natural History of Albuminuria in Pediatric Sickle Cell Anemia

Jeffrey Lebensburger, DO, MSPH, Lee Hilliard, MD, Thomas H. Howard, MD, Inmaculada Aban, PhD, Daniel Feig, MD

Blood (2018) 132 (Supplement 1): 8.

https://doi.org/10.1182/blood-2018-99-115063

Published: 2018

Journal Articles

Clinical and Laboratory Benefits of Early Initiation of Hydroxyurea with Pharmacokinetic Guided Dosing for Young Children with Sickle Cell Anemia

Patrick T. McGann, MD, Omar Niss, MD, Min Dong, PhD, Anu Marahatta, PhD, Tomoyuki Mizuno, PhD, Karen Kalinyak, MD, Theodosia A. Kalfa, MD PhD, Punam Malik, MD, Charles T. Quinn, MD, Russell E. Ware, MD PhD, Alexander A. Vinks, PharmD, PhD FCP

Blood (2018) 132 (Supplement 1): 507.

https://doi.org/10.1182/blood-2018-99-112909

Published: 2018

Journal Articles

Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction

Ioannis Papassotiriou, PhD, Christos Poziopoulos, MD, Katerina Larissi, MD, Alexandra Margeli, Marianna Politou, MD, Evangelos Terpos, MD, Ersi Voskaridou

Blood (2017) 130 (Supplement 1): 3520.

https://doi.org/10.1182/blood.V130.Suppl_1.3520.3520

Published: 2017

Journal Articles

Ambulatory Hypertension in a Pediatric Cohort of Sickle Cell Disease

Divya G Moodalbail, MD, Bonita Falkner, MD

Blood (2017) 130 (Supplement 1): 984.

https://doi.org/10.1182/blood.V130.Suppl_1.984.984

Published: 2017

Journal Articles

Exploring the Clinical Utility of Renal Safety Biomarkers during Iron Chelation Therapy in Patients with β-Thalassemia and Other Anemias

Maria Domenica Cappellini, MD, Erhard Quebe-Fehling, PhD, Celine Pallaud, Frank Dieterle, John B. Porter, BA MB BChir MRCP(Path) FRCP(Path) MD

Blood (2017) 130 (Supplement 1): 4762.

https://doi.org/10.1182/blood.V130.Suppl_1.4762.4762

Published: 2017

Journal Articles

Circulating Adiponectin and Markers of Endothelial and Cardiovascular Dysfunction Correlate with Disease Burden in Newly Diagnosed Patients with Multiple Myeloma; Increase of Adiponectin after Bortezomib- and IMiD-Based Regimens

Evangelos Terpos, Ioannis Papassotiriou, Efstathios Kastritis, MD, Gerasimos-Petros Papassotiriou, Dimitrios Christoulas, Nikolaos Kanellias, Anna Komitopoulou, Evangelos Eleutherakis-Papaiakovou, Ioannis Panagiotidis, Maria Gavriatopoulou, Emilia Mantzou, Meletios A. Dimopoulos

Blood (2016) 128 (22): 4446.

https://doi.org/10.1182/blood.V128.22.4446.4446

Published: 2016

Journal Articles

Management of Severe Chronic Pain with Methadone in Pediatric Patients with Sickle Cell Disease

Zachary LeBlanc, MD, Chris Vance, Jie Zhang, PhD, Sabrina R Macksoud, CRNP, ANP-BC, Steffane Battle, MD, Lee Hilliard, MD, Jeff D. Lebensburger, DO, Thomas H. Howard, MD

Blood (2016) 128 (22): 3663.

https://doi.org/10.1182/blood.V128.22.3663.3663

Published: 2016

Journal Articles

Severe Anemia As an Early Predictor of Kidney Injury

Jeffrey D. Lebensburger, DO MSPH, Sujatha Baddam, MBBS, Inmaculada Aban, PhD, Thomas H. Howard, MD, Lee Hilliard, MD, Daniel Feig, MD PhD MS

Blood (2016) 128 (22): 3670.

https://doi.org/10.1182/blood.V128.22.3670.3670

Published: 2016

Journal Articles

Renal Status and Hematuria in Older Patients with Hemophilia

Pal André Holme, PhDMD, Robert Campbell Tait, MD, Christophe Combescure, PhD, Erik Berntorp, MD PhD, Annarita Tagliaferri, Peter Staritz, MD, Roger E.G. Schutgens, MD PhD, Robert Klamroth, Natascha Marquardt, Stephan Rauchensteiner, Philippe De Moerloose, MD PhD

Blood (2015) 126 (23): 2290.

https://doi.org/10.1182/blood.V126.23.2290.2290

Published: 2015

Journal Articles

Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with Beta-Thalassemia Major

M Akif Yesilipek, MD, Gulsun Karasu, MD, Zuhre Kaya, MD, Baris B Kuskonmaz, MD, Vedat Uygun, MD, Ilkiz Dag, MD, Asli Birkent, MD, Mehmet Ertem, MD

Blood (2015) 126 (23): 959.

https://doi.org/10.1182/blood.V126.23.959.959

Published: 2015

Journal Articles

Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia

Patrick T. McGann, MD MS, Min Dong, PhD, Russell E. Ware, MD PhD, Alexander A Vinks, PharmD, PhD

Blood (2015) 126 (23): 982.

https://doi.org/10.1182/blood.V126.23.982.982

Published: 2015

Journal Articles

Estimation of Glomerular Filtration Rate (GFR) Using Serum Cystatin C and Creatinine Has Poor Precision and Accuracy in Adults with HbSS Sickle Cell Disease

Marianne E. Yee, MD MSc, Peter A. Lane, MD, James R. Eckman, MD, Antonio Guasch, MD

Blood (2015) 126 (23): 987.

https://doi.org/10.1182/blood.V126.23.987.987

Published: 2015

Journal Articles

Serum Peptidome Based Multiple Myeloma Renal Impairment Biomarker Screening

Ju Bai, Aili He, Wanggang Zhang, Yun Yang, Jianli Wang, Pengyu Zhang, Yuandong Feng, Lei Zhang, Hongli Chen, Xiaman Wang, Xiaoru Lei, Ying Shen, Lingjuan Huang

Blood (2015) 126 (23): 2968.

https://doi.org/10.1182/blood.V126.23.2968.2968

Published: 2015

Journal Articles

Chronobiology of Hypertension in Sickle Cell Disease

Jeffrey D. Lebensburger, DO, Daniel Feig, MD, Lee Hilliard, MD, David Askenazi, MD, Thomas H. Howard, MD, Gary Cutter, PhD

Blood (2014) 124 (21): 4094.

https://doi.org/10.1182/blood.V124.21.4094.4094

Published: 2014

Journal Articles

Renal Dysfunction in Pediatric Thalassemia Major Patients and Evaluation of Urine NGAL Levels in Thalassemia

Gulcihan Ozek, Özgür Carti, Erkin Serdaroglu, Serap Cuhadar, Yöntem Yaman, Yesim Oymak, MD, Burcak Gunes, Salih Gözmen, Canan Vergin, MD

Blood (2014) 124 (21): 4049.

https://doi.org/10.1182/blood.V124.21.4049.4049

Published: 2014

NARROW

Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts for Renal Response in Myeloma Patients with Severe Renal Impairment

The Effect of the Soluble Guanylate Cyclase Stimulator Olinciguat on Renal Function and Biomarkers of Inflammation and Renal Injury in Sickle Cell Mice

The Impact of Different Pediatric Estimated GFR Equations on Reporting of Renal Outcomes

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Orosomucoid As a Biomarker for Chronic Kidney Disease Associated with Sickle Cell Anemia

Impact of Hyperfiltration during Early Childhood on the Natural History of Albuminuria in Pediatric Sickle Cell Anemia

Clinical and Laboratory Benefits of Early Initiation of Hydroxyurea with Pharmacokinetic Guided Dosing for Young Children with Sickle Cell Anemia

Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction

Ambulatory Hypertension in a Pediatric Cohort of Sickle Cell Disease

Exploring the Clinical Utility of Renal Safety Biomarkers during Iron Chelation Therapy in Patients with β-Thalassemia and Other Anemias

Circulating Adiponectin and Markers of Endothelial and Cardiovascular Dysfunction Correlate with Disease Burden in Newly Diagnosed Patients with Multiple Myeloma; Increase of Adiponectin after Bortezomib- and IMiD-Based Regimens

Management of Severe Chronic Pain with Methadone in Pediatric Patients with Sickle Cell Disease

Severe Anemia As an Early Predictor of Kidney Injury

Renal Status and Hematuria in Older Patients with Hemophilia

Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with Beta-Thalassemia Major

Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia

Estimation of Glomerular Filtration Rate (GFR) Using Serum Cystatin C and Creatinine Has Poor Precision and Accuracy in Adults with HbSS Sickle Cell Disease

Serum Peptidome Based Multiple Myeloma Renal Impairment Biomarker Screening

Chronobiology of Hypertension in Sickle Cell Disease

Renal Dysfunction in Pediatric Thalassemia Major Patients and Evaluation of Urine NGAL Levels in Thalassemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only